MyRx is a mobile technology innovation that uses real time self monitoring and decision support to deliver a personalized medication adherence program that is adaptable to the patient’s degree of non-adherence. Social network interactions and customizable incentives with feedback reinforcement make this application suitable for chronic illness populations with major depression and/or substance use disorders. Active reminders, and education support are customizable features, based on baseline co-morbid conditions, health literacy, and the complexity of medication regimen. An incentive feature of the application is the integration of a social network rewards system, modeled after addiction recovery programs such as the twelve steps and traditions.
The treatment of chronic illnesses commonly includes the long term use of pharmacotherapy. Although these medications are effective in treating diseases, their full benefits are often not realized because approximately 50% of patients do not take their medications as prescribed. Many factors contribute to poor medication adherence, and include those that are related to patients (eg, poor health literacy and lack of involvement in the treatment decision–making process), those that are related to physicians (eg, prescription of complex drug regimens, communication barriers, ineffective communication of information about adverse effects, and provision of care by multiple physicians), and those that are related to health care systems (eg, office visit time limitations, limited access to care, and lack of health information technology). The human toll and costs of poor medication adherence are staggering: Approximately 125,000 Americans die annually (342 people every day) due to poor medication adherence. Every day, prescription non-adherence costs more than $270 million in additional hospitalization and other medical costs. Nine out of every 10 outpatients are taking prescribed medicines improperly, contributing to prolonged or additional illness. Cost of non-adherence to medications is estimated at approximately $100 billion a year in the U.S. Because barriers to medication adherence are complex and varied, solutions to improve adherence must be multifaceted and integrated. The 2010 health care reform act and the accompanying e-prescribing and electronic medical records (EMR) meaningful use mandates, present a unique opportunity to implement technology innovations that fundamentally address the issue of non adherence at the patient, provider and systems level.


Product Line

Pharmaceutical & Device Companies,

click to request more info